Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV004799529 | SCV001441424 | uncertain significance | Stankiewicz-Isidor syndrome | 2020-02-06 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001836977 | SCV002097780 | uncertain significance | Spermatogenic failure 18 | 2021-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035412 | SCV005012824 | uncertain significance | Inborn genetic diseases | 2024-02-02 | criteria provided, single submitter | clinical testing | The c.211G>T (p.V71L) alteration is located in exon 3 (coding exon 3) of the PSMD12 gene. This alteration results from a G to T substitution at nucleotide position 211, causing the valine (V) at amino acid position 71 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |